Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Tender Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | BI BIOTECH INDIA PRIVATE LIMITEDInferred winner L1₹24,765Qualified Make: R&D Systems
Model: 9439-DG-100
Title: Recombinant Viral Dengue Virus 2 NS1 Protein, CF (100 ug) 328 ANSAL CHAMBER 2 BHIKAJI CAMA PLACE NEW DELHI NEW DELHI SOUTH WEST DELHI DELHI 110066 | NEW DELHI | DELHI | 110066 | Make: R&D Systems
Model: 9439-DG-100
Title: Recombinant Viral Dengue Virus 2 NS1 Protein, CF (100 ug) | L1 | Qualified |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
15 Nov 2023, 12:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Recombinant Viral Dengue Virus 2 NS1 Protein
CF (100 UG) (Q3)
5507956
GEM/2023/B/4128381
Two Packet Bid
Recombinant Viral Dengue Virus 2 NS1 Protein, CF (100 UG)
15 days
Madhya Pradesh; Jabalpur
Total value wise evaluation
PRODUCT_CUSTOM
5 documents required · 5 mandatory
3 yrs
₹3
10%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Recombinant Viral Dengue Virus 2 NS1 Protein | - | - | - |
| CF (100 UG) (Q3) | - | - | - |
Exempted
15 Nov 2023
25 Oct 2023
15 Nov 2023
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5507956.pdf
GEM_BID
spec_dengue_virus_2_ns1_2023-10-25-11-20-44_a8f97b821b24c1e4027bdd86d5d9b601.pdf
SPECIFICATION
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .